clarithromycin

Generic: clarithromycin

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clarithromycin
Generic Name clarithromycin
Labeler asclemed usa, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

clarithromycin 500 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-051
Product ID 76420-051_b21449e8-c203-520d-e053-2995a90ad298
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA065136
Listing Expiration 2026-12-31
Marketing Start 2005-08-25

Pharmacologic Class

Established (EPC)
macrolide antimicrobial [epc]
Mechanism of Action
cytochrome p450 3a4 inhibitors [moa] cytochrome p450 3a inhibitors [moa] p-glycoprotein inhibitors [moa]
Chemical Structure
macrolides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420051
Hyphenated Format 76420-051

Supplemental Identifiers

RxCUI
197517
UNII
H1250JIK0A
NUI
N0000175935 M0028311 N0000182141 N0000190114 N0000185503

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clarithromycin (source: ndc)
Generic Name clarithromycin (source: ndc)
Application Number ANDA065136 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 14 TABLET in 1 BOTTLE (76420-051-14)
  • 20 TABLET in 1 BOTTLE (76420-051-20)
source: ndc

Packages (2)

Ingredients (1)

clarithromycin (500 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b21449e8-c203-520d-e053-2995a90ad298", "openfda": {"nui": ["N0000175935", "M0028311", "N0000182141", "N0000190114", "N0000185503"], "unii": ["H1250JIK0A"], "rxcui": ["197517"], "spl_set_id": ["a12e4d38-e0f8-4467-a26c-bb25a342aa92"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_epc": ["Macrolide Antimicrobial [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "14 TABLET in 1 BOTTLE (76420-051-14)", "package_ndc": "76420-051-14", "marketing_start_date": "20201020"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (76420-051-20)", "package_ndc": "76420-051-20", "marketing_start_date": "20201020"}], "brand_name": "Clarithromycin", "product_id": "76420-051_b21449e8-c203-520d-e053-2995a90ad298", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Macrolide Antimicrobial [EPC]", "Macrolides [CS]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "76420-051", "generic_name": "Clarithromycin", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clarithromycin", "active_ingredients": [{"name": "CLARITHROMYCIN", "strength": "500 mg/1"}], "application_number": "ANDA065136", "marketing_category": "ANDA", "marketing_start_date": "20050825", "listing_expiration_date": "20261231"}